Tagged with P

Brazil Alex Carvalho, general manager Pierre Fabre Brazil, provides insights into the rapidly ascending trajectory of the company in Brazil, its utmost commitment to oncology in the country, and Pierre Fabre’s eagerness to further investing in this strategic market. He also calls for a greater collaboration between all stakeholders to tackle…

Lithuania Mantas Katinas, general manager at Invest Lithuania, discusses the country’s strengths, how it can become an attractive destination for Foreign Direct Investment (FDI) and the commitment of the agency towards developing a proper ecosystem for life sciences in Lithuania. Mr. Katinas, you worked in the telecoms industry before joining Invest…

Switzerland Jeff Dufour, country manager Switzerland and BU lead Internal Medicine at Pfizer, discusses his first impressions of the country, his priorities for greater dialogue with Swiss healthcare insurers, and Switzerland’s potential as a ‘test market’ for the company. Can you give our international readers an outline of your background and…

Serbia Milica Glisic, with over 15 years of experience in the pharma business and ten years at Wörwag Pharma, discusses the strong workforce in the Balkans, Wörwag Pharma’s mission in the West Balkan region, and the company’s dedication to providing unique and efficient solutions for diabetes and concomitant complications. Could you…

Canada Dr. Jean-Yves Leroux, CEO and founder of Medelys, lets his entrepreneurial fiber shine through in this interview as he talks about the beginnings of his company in 2006, the initial challenges, and the prospects for collagen-based natural health products in the treatment of joint pain resulting from arthritis and osteoporosis…

Switzerland Petra Doerr, head of sector communication & networking as well as deputy executive director of Swissmedic, the Swiss surveillance authority for medicines and medical devices, discusses changes to the Swiss regulatory system and harmonizing the organization with its global counterparts. Swissmedic has embarked upon a comprehensive overhaul of its regulations in response…

Canada Dr. John Sampalis, CEO of JSS talks about the impact that changes in the global R&D landscape have had on JSS, the role technology is playing in running an efficient clinical trial program and the company’s next exciting move into the US. John, what have been the main milestones of…

Canada Mark Nawacki, CEO and co-founder of Searchlight Pharma, affirms the company’s dedication to women’s health through a modern approach to current market trends. He underlines the company’s commitment to productive collaborations with healthcare professionals and industry partners and its aspiration to bring life-changing innovations to Canadian patients. Mark, can you…

Poland Jakub Szulc, director of life sciences at EY Poland, discusses the exciting opportunities that exist within the healthcare sector in the flourishing Polish economy and the overriding need to increase healthcare spending as the nation prepares for demographic changes in the future. Furthermore, he highlights the innovative services EY provides…

Canada Dr. Janice E. Parente, president and founder of ethica CRO, explains what led her company to work with pharmaceutical companies internationally and how ethica CRO’s accreditations are an emblem of excellence. Furthermore, she presents ideas on how Canada could be more competitive in terms of R&D globally, by converting its…

Brazil Leandro Pinheiro Safatle, executive secretary of the Brazilian Drug Market Regulation Chamber (CMED) explains why pharmaceuticals was the only sector to have resisted the country’s recent recession, the role that CMED has played in stabilizing the price evolution of medicines in Brazil, and the importance of increasing the regulatory framework’s…

Austria Albin Egger, country representative of UCB Pharma Austria, discusses the strong performance of the Austrian affiliate within the global group, organizational restructuring, and the receptiveness of Austria to UCB’s innovative products. Globally, UCB registered nine percent growth for the first nine months of 2017. How would you describe the contribution…